This project assessed changes in opioid use disorder (OUD) treatment utilization and expenditures in the employer-sponsored private health insurance market during 2007 and 2014. These years mark periods before and after implementation of major federal legislation enacted to increase insurance coverage and expand access to coverage of behavioral health care, the introduction and expanded use of new opioid treatment medications, and other initiatives to expand substance use disorder treatment access.
Use of Medication-Assisted Treatment for Opioid Use Disorders in Employer-Sponsored Health Insurance: Out-of-Pocket Costs
Publication Date